MPG.eBooks - Search Results

Cover Image

81

CADTH Canadian Drug Expert Committee recommendation: Dolutegravir/Rilpivirine (Juluca -- ViiV healthcare) : indication : the treatment of human immunodeficiency virus (HIV-1) infec...

Published 2018

CADTH

Cover Image

82

CADTH Canadian Drug Expert Committee recommendation: Fluticasone Propionate (Aermony respiclick -- Teva Canada Innovation) : indication : maintenance treatment of asthma in patient...

Published 2018

CADTH

Cover Image

83

CADTH Canadian Drug Expert Committee recommendation: Insulin degludec and liraglutide (Xultophy -- Novo Nordisk Canada Inc.) : indication : adjunct to lifestyle modifications, for...

Published 2019

CADTH

Cover Image

84

CADTH Canadian Drug Expert Committee final recommendation: Selexipag (Uptravi -- Actelion Pharmaceuticals Canada Inc.) : Indication: pulmonary arterial hypertension

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

85

CADTH Canadian drug expert committee recommendation: Latanoprost (Monoprost -- Laboratoires Thea) : indication : glaucoma and ocular hypertension

Published 2018

Canadian Agency for Drugs and Technologies in Health

Cover Image

86

CDEC final recommendation: Dolutegravir (Tivicay -- ViiV Healthcare ULC) : indication : HIV infection

Published 2014

Canadian Agency for Drugs and Technologies in Health

Cover Image

87

CADTH Canadian drug expert committee recommendation: Siponimod (Mayzent -- Novartis Pharmaceuticals Canada Inc.) : indication : secondary progressive multiple sclerosis

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

88

CADTH Canadian drug expert committee recommendation: Cysteamine ophthalmic solution (Cystadrops -- recordati rare diseases Canada Inc.) : indication : treatment of corneal cystine...

Published 2019

Canadian Agency for Drugs and Technologies in Health

Cover Image

89

CADTH Canadian Drug Expert Committee recommendation: Budesonide (Jorveza--Avir Pharma Inc.) : indication : eosinophilic esophagitis

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

90

CADTH Canadian Drug Expert Committee recommendation: Eculizumab (Soliris -- Alexion Pharma Canada Corp.) : indication : adult patients with refractory generalized myasthenia gravis

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

91

CADTH Canadian Drug Expert Committee recommendation: Indacaterol/Mometasone Furoate (Atectura Breezhaler -- Novartis Pharmaceuticals Canada Inc.) : indication: asthma maintenance (...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

92

CADTH Canadian Drug Expert Committee recommendation: Indacaterol/glycopyrronium/mometasone furoate (Enerzair Breezhaler -- Novartis Pharmaceuticals Canada Inc.) : indication: asthm...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

93

CADTH Canadian Drug Expert Committee recommendation: Eculizumab (Soliris - Alexion Pharma Canada Corp.) : indication : the treatment of neuromyelitis optica spectrum disorder (NMOS...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

94

CADTH Canadian Drug Expert Committee recommendation: Etonogestrel extended-release subdermal implant (Nexplanon -- Merck Canada Inc.) : indication : prevention of pregnancy for up...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

95

CADTH Canadian Drug Expert Committee recommendation: Nintedanib (Ofev -- Boehringer Ingelheim Canada Inc.) : indication: chronic fibrosing interstitial lung diseases

Published 2021

Canadian Agency for Drugs and Technologies in Health

Cover Image

96

CADTH Canadian Drug Expert Committee recommendation: Vedolizumab (Entyvio -- Takeda Canada Inc.) : indication: for the treatment of adult patients with moderately to severely activ...

Published 2021

Canadian Agency for Drugs and Technologies in Health

Cover Image

97

CADTH Canadian Drug Expert Committee recommendation: Ranolazine (Corzyna -- KYE pharmaceuticals Inc.) : indication: patients with stable angina pectoris who are inadequately contro...

Published 2021

Canadian Agency for Drugs and Technologies in Health

Cover Image

98

CADTH Canadian Drug Expert Committee Recommendation: Onabotulinumtoxin A (Botox -- Allergan Inc.) : indication: chronic migraine

Published 2019

CADTH

Cover Image

99

CADTH Canadian Drug Expert Committee recommendation: Iron isomaltoside 1000 (Monoferric -- pharmacosmos A/S) : indication: for the treatment of iron deficiency anemia in adult pati...

Published 2020

CADTH

Cover Image

100

CADTH Canadian Drug Expert Committee recommendation: Caplacizumab (Cablivi -- Sanofi-Aventis Canada Inc.) : indication : for the treatment of adults with acquired thrombotic thromb...

Published 2020

Canadian Agency for Drugs and Technologies in Health

1
2
3
4
5
6
7
8
9
10
11